Last reviewed · How we verify
NCT04096651: Gait-PSP
Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy
NA trial testing gait recordings in Progressive Supranuclear Palsy in 48 participants. Completed in 12 July 2018.
12 July 2018
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Guadeloupe |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 48 |
| Start date | 28 September 2015 |
| Primary completion | 12 July 2018 |
| Estimated completion | 12 July 2018 |
Drugs / interventions tested
- gait recordings
- brain magnetic resonance imaging
- oculomotor movement recordings
Conditions studied
- Progressive Supranuclear Palsy — all drugs for Progressive Supranuclear Palsy →
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Who can join
40 and older, any sex, with Progressive Supranuclear Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main hypothesis is that the gait and postural deficits in the Caribbean form of PSP may be associated with a dysfunction of the cerebral cortex, as they result from sub-cortical involvement in classical forms. The investigators will characterize the gait and posture with a force platform to collect biomechanical gait parameters, coupled with the kinematic and electromyographic (EMG) study. Then the investigators realize a multimodal imaging study \[structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI)\] that allow us to determine if a correlation can be found between the clinical characteristics of postural control and walking on one hand, and morphological changes and structural MRI changes in cortico-subcortical pathways on the other hand. The study of performance on neuropsychological tests, registration of ocular movements and the analysis of functional cortical activity will complete our multimodal approach. A better understanding of these disorders is expected to propose new drug treatment and rehabilitative strategies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Brain dysfunction in gait disorders of Caribbean atypical Parkinsonism and progressive supranuclear palsy patients: A comparative study.
Welter ML, Vasseur A, Edragas R, Chaumont H, et al · · 2023 · cited 4× · PMID 37247501 · DOI 10.1016/j.nicl.2023.103443
Verify or expand the search:
- PubMed search for NCT04096651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Progressive Supranuclear Palsy
Currently open trials in the same condition.
- NCT06588673 — Art Therapy in Progressive Supranuclear Palsy · NA · active not recruiting
- NCT06647641 — The CurePSP Genetics Program · recruiting
- NCT06174948 — The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders · NA · recruiting
- NCT06122662 — AMX0035 and Progressive Supranuclear Palsy · Phase 2, PHASE3 · active not recruiting
- NCT05956834 — A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes · active not recruiting
Other Centre Hospitalier Universitaire de la Guadeloupe trials
Trials by the same sponsor.
- NCT07266376 — Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS · NA · not yet recruiting
- NCT07292454 — Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe · not yet recruiting
- NCT07265986 — Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart · NA · recruiting
- NCT07330830 — Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (A · recruiting
- NCT07233447 — Prevalence of H. Pylori in Stomach Cancers in the West Indies · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04096651 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Guadeloupe
- Last refreshed: 20 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04096651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing